Kampf A, Pillar C J, Woodford W J, Mertes M P
J Med Chem. 1976 Jul;19(7):909-15. doi: 10.1021/jm00229a010.
A series of thymidylate synthetase inhibitors was synthesized, some of which were potential irreversible inhibitors. 5-Formyl-2'-deoxyuridine (9) and its dithiolane derivative 11 were prepared by condensation of the bis(trimethylsilyl) derivative of 5-formyluracil dimethyl acetal and the protected chloro sugar followed by saponification of the protective groups. 5-Acetyl-2'-deoxyuridine (15) was prepared in the same way from 5-acetyluracil. Treatment of the diester of 5-allyl-2'-deoxyuridine (17 or 22) with m-chloroperbenzoic acid gave the corresponding epoxide. Dimethylamine removed the ester groups and opened the epoxide to give the amino alcohol 24. The diester of 5-chloromethyl-2'-deoxyuridine (27) treated with methanol or sodium azide gave 5-methoxymethyl- (29) and 5-azidomethyl- (31) 2'-deoxyuridines. Compound 27 also was converted to 5-iodoacetamidomethyl-2'-deoxyuridine by treatment with ammonia, chloroacetyl chloride, base saponification, and finally sodium iodide.
合成了一系列胸苷酸合成酶抑制剂,其中一些是潜在的不可逆抑制剂。5-甲酰基-2'-脱氧尿苷(9)及其二硫杂环戊烷衍生物11是通过5-甲酰基尿嘧啶二甲基缩醛的双(三甲基硅基)衍生物与保护的氯代糖缩合,然后脱去保护基制备的。5-乙酰基-2'-脱氧尿苷(15)以同样的方式由5-乙酰基尿嘧啶制备。用间氯过苯甲酸处理5-烯丙基-2'-脱氧尿苷的二酯(17或22)得到相应的环氧化物。二甲胺脱去酯基并打开环氧化物得到氨基醇24。用甲醇或叠氮化钠处理5-氯甲基-2'-脱氧尿苷的二酯(27)得到5-甲氧基甲基-(29)和5-叠氮甲基-(31)2'-脱氧尿苷。化合物27还通过用氨、氯乙酰氯处理、碱皂化,最后用碘化钠处理转化为5-碘乙酰胺甲基-2'-脱氧尿苷。